MadeMed GLP-1 Cost Comparison 2026: How Its Pricing Stacks Up

I keep a spreadsheet of compounded GLP-1 prices, and every few weeks a new telehealth name lands in it. MadeMed is one of the more competitive rows. If you’ve priced a month of Wegovy at a pharmacy counter and felt your stomach drop, the numbers here are a different planet — and that gap is exactly why the compounded market exists. So let’s do the thing most reviews skip and actually run a MadeMed GLP-1 cost comparison against the wider compounded field, month by month, fee by fee, instead of hand-waving about “affordability.”

What MadeMed charges, in plain numbers

MadeMed’s compounded semaglutide starts around $169 a month, and its tirzepatide starts around $189. On top of that sits a MadeMed Club membership at roughly $149 a year — so if you’re annualizing, budget the membership as about $12–13 a month layered onto the medication. The platform offers both injectable and oral versions of each drug, which matters if needles aren’t your thing. It’s LegitScript certified and HIPAA-compliant, and a licensed clinician reviews your intake before anything ships.

One thing to say early and clearly: compounded semaglutide and tirzepatide are not FDA-approved finished products. They’re prescribed by a licensed provider and made by a pharmacy, and whether they’re right for you is your prescriber’s call, not a shopping decision. That’s true of MadeMed and every competitor in the table below.

MadeMed GLP-1 cost comparison vs the compounded field

Here’s where MadeMed sits against the typical spread of compounded telehealth programs and the brand-name drugs it’s undercutting. Compounded programs generally run anywhere from about $99 to $299 a month depending on drug, dose, and whether coaching is bundled in.

Option	Starting monthly cost	Membership / extras	FDA status
MadeMed (compounded sema)	~$169	~$149/yr club fee	Compounded, not FDA-approved
MadeMed (compounded tirz)	~$189	~$149/yr club fee	Compounded, not FDA-approved
Typical compounded field	~$99–$299	Varies (often monthly)	Compounded, not FDA-approved
Wegovy (brand semaglutide)	~$1,350–$1,640	Insurance-dependent	FDA-approved
Zepbound (brand tirzepatide)	~$1,271	Insurance-dependent	FDA-approved

Read the table and two things jump out. MadeMed lands in the lower-middle of the compounded pack on the sticker price — not the rock-bottom cheapest, but close. And against brand-name drugs, the compounded route as a whole is roughly a tenth of the cost. That’s the real story of this market, and it’s why nearly half of U.S. adults — obesity affects about 42% per NIH figures — now have a cash-pay path that didn’t exist a few years ago.

Where the annual fee changes the math

The $149 club fee is the detail that makes MadeMed’s comparison tricky. A program advertising “$199/month, no membership” can actually cost less over a year than a “$169 + $149/year” setup once you add it all up. Run your own 12-month total before you commit. Here’s my honest gripe: annual membership fees are the oldest trick in subscription pricing, because they make the monthly headline look smaller than your real spend. MadeMed isn’t hiding it, but you do have to do the arithmetic yourself, and a lot of people won’t.

Where MadeMed earns some of that fee back is the oral option. If you’ve tried injections and hated them, an oral compounded semaglutide or tirzepatide at a similar price point is genuinely useful, and not every budget competitor offers it.

Who MadeMed’s pricing actually fits

Price shopping only tells you half the story, so here’s the practical read. MadeMed makes the most sense for someone who’s fairly sure they’ll stay on treatment for at least a year — that’s the horizon where the $149 club fee stops stinging and the low medication cost starts working in your favor. Spread across twelve months, the membership is a rounding error against what you’d pay for a single week of brand-name Zepbound. For a committed, long-haul user, that math is hard to argue with.

It fits less well for the tire-kicker. If you’re not certain GLP-1 therapy is for you and you want to try a single month before deciding, paying an annual fee upfront to unlock a $169 rate is a worse deal than a slightly pricier month-to-month program with no lock-in. There’s no shame in starting on the more flexible option and switching to MadeMed once you know you’re staying. The cheapest sticker price and the cheapest actual outcome aren’t always the same program, and which one wins depends entirely on how long you plan to stick with it.

The 2026 fine print worth knowing

The compounded space is under active review this year. In April 2026 the FDA proposed excluding semaglutide and tirzepatide from the 503B compounding bulks list, with a public comment period that closed at the end of June. Nothing in that changes MadeMed’s pricing today, but it’s a reminder that access to compounded GLP-1s isn’t guaranteed to look the same in twelve months. If a low monthly number is the whole reason you’re choosing this route, factor in that the regulatory ground can shift. GLP-1 medications also carry real side effects and aren’t appropriate for everyone — this is a cost review, not medical advice, and your clinician decides.

Frequently asked questions

Is MadeMed cheaper than the average compounded GLP-1 program?

On the medication itself, roughly yes — its ~$169 semaglutide start sits in the lower half of the typical $99–$299 range. But once you add the ~$149 annual club fee, a no-membership competitor can end up cheaper over a full year, so compare 12-month totals, not headline monthly rates.

Does the price include the doctor’s consultation?

MadeMed’s model bundles the licensed clinician review into the program rather than charging a separate visit fee, and shipping is typically included. Always confirm at checkout, since dose changes can move the monthly medication cost.

Why is compounded semaglutide so much less than Wegovy?

Brand-name Wegovy and Zepbound carry the manufacturer’s pricing and FDA-approved status, running well over $1,000 a month cash. Compounded versions are made by pharmacies at cash-pay rates, which is how a program like MadeMed lands near $169–$189 — but they trade away that FDA-approved finished-product status.

Will my MadeMed cost stay the same as my dose increases?

Not necessarily. GLP-1 dosing usually steps up over the first few months, and compounded pricing can rise with higher doses. Ask MadeMed for the full dose-by-dose price ladder so you’re budgeting for month six, not just month one.